MEXICO CITY, Oct. 25, 2014 /PRNewswire/ -- Taro Pharma Inc., an international pharmaceutical company, today announced the successful completion of a Phase III clinical trial for tetracycline and doxycycline hydrochloride (TCH) as monotherapy in the treatment of meningiomas in the meningioma group.
"We are very pleased that we have successfully completed the Phase III study, which is the first in the world for the treatment of meningiomas in the meningioma group," said John M. Smith, MD, Vice President, R & D at Taro, and Chief Executive Officer of Taro.
Taro, a multinational pharmaceutical company that manufactures and markets a variety of generics and specialty pharmaceutical products, is the leading supplier of tetracycline hydrochloride and doxycycline hydrochloride. Taro is an international pharmaceutical company committed to supporting the growth of its pharmaceuticals worldwide and delivering a range of products in the therapeutic areas of dermatology, pediatrics and human immunodeficiency virus.
Taro, based in Mérida, Mexico, has a large presence in both the U. S. and Europe and a presence in more than 50 countries worldwide. Taro's commercial operations include manufacturing and distributing pharmaceuticals for over 100 countries and territories. As an international pharmaceutical company, Taro focuses on the development and commercialization of pharmaceutical products in the pharmaceutical therapeutic areas of dermatology, pediatrics and human immunodeficiency virus, and on the development of innovative drugs for the treatment of diseases associated with immune system-mediated diseases, including cancer and inflammatory diseases such as leukaemia.
The Phase III clinical trial was conducted at Taro's site in Mérida, Mexico, in collaboration with the National Center for Complementary and Health-Related Therapies (NCGH), which is a part of Taro's Center for Drug Evaluation and Research (CORD) in collaboration with the National Institute of Allergy and Infectious Diseases, and the University of Texas MD Anderson Cancer Center. The Phase III trial will evaluate the safety and efficacy of tetracycline hydrochloride and doxycycline hydrochloride monotherapy in meningiomas following treatment with these agents in adults.
"We are pleased to have completed the first Phase III clinical study in this indication and are very pleased to be able to be one of the first to provide the highest standard of care," said Dr. Smith.
Taro has submitted an application for the first US-licensed generic formulation of doxycycline hydrochloride for sale through its international mail order pharmacy program in the U. and Canada. Taro currently holds a patent on doxycycline hydrochloride, which is indicated for the treatment of meningiomas in the meningioma group in the meningioma group.
Taro is also developing a generic formulation of tetracycline hydrochloride for sale through its international mail order pharmacy program in the U.
In addition to the Phase III trial, Taro will also initiate and maintain a global partnership with the U. Department of Health and Human Services (HHS) to evaluate the safety and efficacy of Tetracycline Hydrochloride (TCH) in the treatment of meningiomas.
Meningiomas, defined as non-neoplastic meningiomas in the meningioma group, are the most common type of tumors among men and women, occurring in more than half of all meningiomas diagnosed during clinical trials, and are characterized by a central or peripheral meningioma with a growth pattern that includes a recurrence at least twice within the previous 12 months. The most common clinical entity in the meningioma group is meningiomas (99%) at the site of the tumor. Other tumors include oesophageal and esophageal carcinomas, endometrial carcinomas, and malignant melanoma.
Tetracycline hydrochloride is an oral tablet that has been approved by the U. Food and Drug Administration (FDA) to treat moderate to severe acne, rosacea, and psoriasis, as well as for the treatment of certain inflammatory diseases including rheumatoid arthritis and osteoarthritis. Tetracycline hydrochloride is not approved for the treatment of benign prostatic hyperplasia.
VETORIA, Mexico (AP) — U. S. Customs and Border Protection (CBP) officers found a shipment containing an antibiotic, doxycycline, nearly three months after it was seized in Mexico. The shipment was headed to an online pharmacy in Mexico.
The shipment was headed to an online pharmacy in Mexico, where it was sold in the United States and sold through online auction websites. The shipment was headed to the United States, where it was sold online for about $2,500 each.
When CBP officers seized the shipment, they found the following chemical ingredients: Doxycycline hyclate, the active ingredient in doxycycline.
After a thorough search, they found that the shipment contained tetracycline, a synthetic antibiotic used to treat skin infections caused by bacteria. Tetracycline is a type of antibiotic that helps to stop bacteria from multiplying.
According to the CBP website, tetracycline is an effective antibiotic for treating various bacterial infections, including Lyme disease, acne, and some sexually transmitted diseases.
The CBP officers seized the shipment through a customs facility, where they received a letter of intent from the Customs Service, indicating that they had the shipment with them.
In the letter, the CBP officer noted that the shipment had been addressed to an online pharmacy in Mexico and that the online pharmacy was selling drugs online. The online pharmacy listed a physical address and a shipping address in the letter of intent, as well as a phone number and an email address.
The officers found that the shipment had been shipped to an address in the United States and that the online pharmacy had a physical address and phone number in the United States.
When they contacted the U. Department of Homeland Security (DHS), they had no response to CBP’s request for an address and an email address, according to CBP’s website.
A CBP officer working for the Department of Homeland Security, Michael B. Johnson, confirmed that CBP is the agency responsible for the investigation of online pharmacy operations in the United States. CBP officers were unable to find the online pharmacy.
The CBP officers have not been able to locate the online pharmacy because it is located in Mexico. CBP officers in the United States are responsible for enforcing the online sale of prescription drugs, which are regulated and widely available in the United States.
Doxycycline is a widely used antibiotic that has been used for more than 100 years to treat a wide range of bacterial infections. However, it’s important to note that it has some limitations and may not be suitable for everyone. One of the most important points of this medication is the potential side effects of doxycycline.
Here is a quick look at doxycycline for your acne treatment.
Doxycycline is a tetracycline antibiotic that belongs to the tetracycline group. It is effective against a wide range of bacterial infections and is often prescribed for acne.
Doxycycline works by inhibiting bacterial protein synthesis, which helps to kill bacteria and reduce inflammation. This is particularly beneficial for acne treatment, where the skin is often the culprit in blemishes and scaling.
Doxycycline is usually taken once daily, with the recommended dosage for adults is usually 2.5 mg or 5 mg per day. The medication should be taken in the morning, and the dose can be adjusted to the prescribed dose depending on the severity of the infection. The usual dosage for adults is usually taken once daily. However, it’s important to note that taking it daily can cause side effects like nausea, diarrhea, or headaches.
It’s important to follow the instructions provided by your healthcare provider to ensure the medication is taken properly. This includes taking doxycycline as prescribed and not to exceed the recommended dose. Do not stop taking the medication without consulting your doctor first.
While doxycycline is generally well-tolerated, there are some potential side effects of using this medication. Common side effects include nausea, vomiting, and abdominal pain. These symptoms can be uncomfortable but should not be ignored. If you experience any unusual symptoms, it is important to contact your healthcare provider immediately.
If you have any side effects or concerns while using doxycycline, it is recommended to speak with your healthcare provider to find out more. They can discuss ways to manage side effects and monitor their effectiveness.
The most common side effects of doxycycline include the following:
These are not all, some may be more serious and require immediate medical attention.
While it’s important to be patient and aware of any side effects, it’s essential to understand that these are just a few of the possible side effects of doxycycline. While they are relatively rare, it is important to be aware of them and to speak with your healthcare provider if you have any concerns.
To manage side effects, it’s crucial to take doxycycline as prescribed. It is also important to follow the instructions provided by your healthcare provider and avoid taking any medications that have been taken without asking them. If you have any concerns about side effects, talk with your healthcare provider or pharmacist to find the best way to manage your side effects.
Doxycycline is often prescribed for acne treatment, but it’s important to be aware of its uses.
Some of the best uses of doxycycline are:
In addition, it’s important to discuss all possible uses with your healthcare provider, and to talk to them about any potential side effects that may arise.
Give as directed by your veterinarian. Follow the instructions printed on the prescription label. Store doxycycline at room temperature. Be sure to complete the prescription to ensure a full recovery, even if your pet seems to be improving, unless instructed otherwise by your veterinarian. Allow your pet access to plenty of water. Doxycycline can be given with or without food but should not be given with dairy products.
Keep out of the reach of children and pets. Do not use in animals with a known sensitivity to doxycycline. Do not use in pregnant animals. Let your veterinarian know if your pet is on any other medications, as interactions with certain medicines can occur. Do not administer any calcium-containing medications, antacids, laxatives, or multivitamins within 2 hours of the last doxycycline dose. Notify your veterinarian if your animal suffers from kidney or liver disease. Doxycycline may increase skins sensitivity to sunlight. Store at room temperature. Store protected from light and moisture.
Allergic reactions and serious side effects are rare, but in the case of an allergic reaction or a serious side effect you should stop doxycycline treatment and seek veterinary attention. Some common signs of allergic reactions and serious side effects are hives, breathing difficulty, facial swelling, loss of appetite, or dark colored urine.
Should be stored at room temperature, away from moisture and heat.
Doxycycline should not be used in animals allergic to it or other tetracycline antibiotics. Use with caution in animals with impaired liver or kidney function. Do not use in pregnant, nursing, or growing animals since this medication may cause slowing of bone growth and discoloration of teeth. Give antacids, vitamin and mineral combinations, iron, or Pepto-Bismol at least 1 hour before or 4 hours after giving doxycycline. Use caution when given with digoxin or warfarin. Doxycycline is not affected by food.
Contains DoxycyclineDoxycycline is a broad-spectrum antibiotic that is effective against a wide range of bacterial infections. It is available in a number of strengths, including Doxycycline (100 mg, 50 mg, and 25 mg), Doxycycline + Doxycycline (100 mg, 200 mg, and 200 mg), Doxycycline + Doxycycline + Tetracycline (100 mg, 200 mg, and 100 mg), Doxycycline + Tetracycline (100 mg, 200 mg, and 100 mg), Doxycycline + Tetracycline + Tetracycline (100 mg, 200 mg, and 100 mg), and Doxycycline + Tetracycline + Tetracycline (100 mg, 200 mg, and 100 mg). Doxycycline is an antibiotic that belongs to the tetracycline class of medications.
Doxycycline is a commonly prescribed antibiotic in Australia and Canada. It is also used to treat a variety of bacterial infections. The use of doxycycline for the treatment of common infections is limited to humans and animals. It can be taken orally as a tablet or as a capsule. It is also used in dogs and cats to treat bacterial infections. Doxycycline can be given by injection, intravenously, or orally. It is usually taken once or twice daily for several weeks.
It is usually given as an intravenous solution or as a capsule.
It is available in a number of strengths, including Doxycycline (100 mg, 50 mg, and 25 mg), Doxycycline + Doxycycline (100 mg, 200 mg, and 100 mg), Doxycycline + Doxycycline + Tetracycline (100 mg, 200 mg, and 100 mg), Doxycycline + Tetracycline + Tetracycline (100 mg, 200 mg, and 100 mg), and Doxycycline + Tetracycline + Tetracycline (100 mg, 200 mg, and 100 mg).
It can be given by injection, intravenously, or orally.
Stade de France Pharmacy